ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
14603.1;5 PFLS-LS
Project title
Human FAP-targeting Antibodies as Infarction Prevention Medications: Proof-of-Concept

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Prof. Dr. med.
Simon Philipp Hoerstrup
Universitätsspital
Zürich
Moussonstrasse 13
CH-8091 Zürich
01 255 87 46
simon_philipp.hoerstrup@chi.usz.ch